Cytek Biosciences
CTKB
CTKB
136 hedge funds and large institutions have $415M invested in Cytek Biosciences in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.02% less ownership
Funds ownership: 58.02% → 57% (-1%)
60% less call options, than puts
Call options by funds: $2K | Put options by funds: $5K
Holders
136
Holding in Top 10
–
Calls
$2K
Puts
$5K
Top Buyers
| 1 | +$7.88M | |
| 2 | +$1.18M | |
| 3 | +$1.08M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.01M |
| 5 |
Morgan Stanley
New York
|
+$957K |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$4.77M | |
| 3 | -$4.19M | |
| 4 |
Goldman Sachs
New York
|
-$1.85M |
| 5 |
DM
Deerfield Management
New York
|
-$765K |